Back

Practical Considerations on Using Omega-3 Fatty Acids to Prevent ASCVD.

31 August 2020 (13:20 - 13:30)
Organised by:
Congress Presentation Part of: Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl Cardiovascular Risk Assessment Open Access ESC Congress 2020

About the speaker

Photo
Professor Borge Nordestgaard

Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Welcome and Introductions, Program Overview.
Professor P. Steg (Paris, FR)
Video
Presentation thumbnail
Hypertriglyceridaemia as a Causal Factor and Target for Therapy.
Professor B. Nordestgaard (Copenhagen, DK)
Video
Presentation thumbnail
Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD.
Professor P. Steg (Paris, FR)
Video
Presentation thumbnail
Live Q&A and Adjourn.
Professor P. Steg (Paris, FR) Professor B. Nordestgaard (Copenhagen, DK)
Video

Access the full session

Session thumbnail
Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 13:20 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial
27 August 2021
thumbnail
Congress Presentation
Icosapent ethyl in clinical practice: the Spanish experience
29 August 2025
thumbnail
Webinar
Arrhythmias and metabolic pathways: new mechanisms, new opportunities
2 June 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources